© 2020 – 2022 AEA3 WEB | AEAƎ China News
NEWS

New diabetes drug approved in China

HuaTangNing (Dorzagliatin Tablets), a first-in-class glucokinase activator (GKA) for Type 2 diabetes (T2D) treatment, was approved by China’s National Medical Products Administration on Sunday.

Related posts

Hurricane forces NASA to delay Artemis I moon rocket launch

AEAƎ

Dangerous stunts get thumbs-down from video platforms

AEAƎ

China willing to strengthen scientific and technological ties with the world, says Xi

AEAƎ